Kennedy Van der Laan and Monard Law advised Blau Farmacêutica on the investment. Blau Farmacêutica, a prominent player in the pharmaceutical industry in the United States...
Blau Farmacêutica’s Investment in Prothya
Blau Farmacêutica’s R$1.1 Billion Initial Public Offering
Simpson Thacher and Machado Meyer represented Blau Farmacêutica S.A. in the transaction. Shearman & Sterling and Lefosse advised Banco Itaú, Banco Bradesco BBI S.A., J.P. Morgan,...